Managing the adverse events associated with epcoritamab treatment: focus on CRS

Описание к видео Managing the adverse events associated with epcoritamab treatment: focus on CRS

Alexey Danilov, MD, PhD, City of Hope, Duarte, CA, comments on the management of side effects associated with epcoritamab, noting that cytokine release syndrome (CRS) is a common adverse event that community physicians should look out for. CRS often requires pre-medication with steroids and adequate hydration before achieving a full step-up dose. This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Комментарии

Информация по комментариям в разработке

Похожие видео